Fenofibrate lowers blood pressure in two genetic models of hypertension.
暂无分享,去创建一个
T W Wilson | T. Wilson | R K Shatara | D W Quest | D. Quest | R. K. Shatara
[1] J. Stockigt,et al. Determination of Plasma Renin Concentration by Angiotensin I Immunoassay , 1971 .
[2] S. Fukuchi,et al. Determination of plasma renin activity by radioimmunoassay of angiotensin I. , 1973, Clinical science.
[3] T. Dimitrov,et al. An attempt to prevent spontaneous hypertension in rats by antihypertensive drug treatment. , 1977, Cor et vasa.
[4] G. Peterson,et al. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. , 1979, Analytical biochemistry.
[5] J. Melby,et al. The effects of hydrochlorothiazide on the renin-aldosterone system. , 1983, Metabolism: clinical and experimental.
[6] B. Brenner,et al. The role of hemodynamic factors in the initiation and progression of renal disease. , 1985, The Journal of urology.
[7] N. Abraham,et al. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. , 1989, Science.
[8] W. Sessa,et al. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. , 1989, The Journal of pharmacology and experimental therapeutics.
[9] R. Becker,et al. Loop Diuretics Combined with an ACE Inhibitor for Treatment of Hypertension: A Study with Furosemide, Piretanide, and Ramipril in Spontaneously Hypertensive Rats , 1989, Journal of cardiovascular pharmacology.
[10] R. Roman,et al. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. , 1993, Hypertension.
[11] R. Roman,et al. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. , 1994, The American journal of physiology.
[12] R. Roman,et al. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. , 1995, Journal of Vascular Research.
[13] N. Abraham,et al. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. , 1996, Nephron.
[14] J Auwerx,et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.
[15] R. Stanfield,et al. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats. , 1996, Atherosclerosis.
[16] B. Brenner,et al. Implications of the linear pressure-natriuresis relationship and importance of sodium sensitivity in hypertension. , 1997, Journal of hypertension.
[17] J. Wright,et al. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. , 1997, American journal of hypertension.
[18] N. Gretz,et al. Acute effects of bezafibrate on blood pressure and renal haemodynamics in SHR and WKY rats. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] R. Roman,et al. Effects of lipid-lowering agents in the Dahl salt-sensitive rat. , 1998, Hypertension.
[20] S Heidenreich,et al. How to assess glomerular function and damage in humans. , 1999, Journal of hypertension.